Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction

Abstract Background Transcatheter arterial embolization (TAE) has been widely performed for renal angiomyolipomas (AMLs) as prophylaxis or emergency treatment. On the other hand, mammalian target of rapamycin (mTOR) inhibitors have recently been used for tuberous sclerosis (TSC)-related AMLs, and no...

Full description

Bibliographic Details
Main Authors: Hidenari Hongyo, Hiroki Higashihara, Keigo Osuga, Eiji Kashiwagi, Shinya Kosai, Keisuke Nagai, Kaishu Tanaka, Yusuke Ono, Takeshi Ujike, Motohide Uemura, Ryoichi Imamura, Norio Nonomura, Noriyuki Tomiyama
Format: Article
Language:English
Published: SpringerOpen 2020-11-01
Series:CVIR Endovascular
Subjects:
Online Access:http://link.springer.com/article/10.1186/s42155-020-00179-2
_version_ 1818531702504423424
author Hidenari Hongyo
Hiroki Higashihara
Keigo Osuga
Eiji Kashiwagi
Shinya Kosai
Keisuke Nagai
Kaishu Tanaka
Yusuke Ono
Takeshi Ujike
Motohide Uemura
Ryoichi Imamura
Norio Nonomura
Noriyuki Tomiyama
author_facet Hidenari Hongyo
Hiroki Higashihara
Keigo Osuga
Eiji Kashiwagi
Shinya Kosai
Keisuke Nagai
Kaishu Tanaka
Yusuke Ono
Takeshi Ujike
Motohide Uemura
Ryoichi Imamura
Norio Nonomura
Noriyuki Tomiyama
author_sort Hidenari Hongyo
collection DOAJ
description Abstract Background Transcatheter arterial embolization (TAE) has been widely performed for renal angiomyolipomas (AMLs) as prophylaxis or emergency treatment. On the other hand, mammalian target of rapamycin (mTOR) inhibitors have recently been used for tuberous sclerosis (TSC)-related AMLs, and no comparison between the effectiveness of mTOR inhibitors versus prophylactic selective TAE has yet been performed. Therefore, the purpose of this study was to evaluate the efficacy of TAE for AML tumor volume reduction and predictors of tumor volume decrease over 50%, with reference to the EXIST-2 trial. Methods A total of 44 patients who underwent 48 prophylactic embolization procedures for 50 AMLs in a single institution between 2004 and 2018 were included. Indications for TAE of AMLs were tumor size ≥4 cm or aneurysm ≥5 mm in diameter on contrast-enhanced computed tomography (CECT). Microspheres, ethanol, and micro-coils were used as embolic agents. The percentage volume reduction from before TAE to the minimum volume during follow-up after TAE was calculated, and predictors for 50% volume reduction were identified by univariate and multivariate binary logistic regression analyses. Results The technical success rate was 100% (50 of 50). No severe acute complications related to the procedure were encountered. Tumor volume reduction of ≥50% was observed in 35/50 AMLs. There was a significant difference in the rate of tumor volume reduction of 50% between the presence and absence of an aneurysm ≥5 mm and between tumor diameter ≥ 70 mm and < 70 mm on univariate analysis. On multivariate analysis, tumor diameter < 70 mm was the only independent predictor of significant tumor volume reduction after TAE. Conclusion Prophylactic selective TAE for AMLs has good tumor-reduction effects, especially for AMLs with tumor diameter < 70 mm.
first_indexed 2024-12-11T17:35:54Z
format Article
id doaj.art-98cb62b7ecf54767a1c11521fbc65143
institution Directory Open Access Journal
issn 2520-8934
language English
last_indexed 2024-12-11T17:35:54Z
publishDate 2020-11-01
publisher SpringerOpen
record_format Article
series CVIR Endovascular
spelling doaj.art-98cb62b7ecf54767a1c11521fbc651432022-12-22T00:56:40ZengSpringerOpenCVIR Endovascular2520-89342020-11-01311710.1186/s42155-020-00179-2Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reductionHidenari Hongyo0Hiroki Higashihara1Keigo Osuga2Eiji Kashiwagi3Shinya Kosai4Keisuke Nagai5Kaishu Tanaka6Yusuke Ono7Takeshi Ujike8Motohide Uemura9Ryoichi Imamura10Norio Nonomura11Noriyuki Tomiyama12Department of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic Radiology, Osaka Medical CollegeDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineDepartment of Urology, Osaka University Graduate School of MedicineDepartment of Urology, Osaka University Graduate School of MedicineDepartment of Urology, Osaka University Graduate School of MedicineDepartment of Urology, Osaka University Graduate School of MedicineDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of MedicineAbstract Background Transcatheter arterial embolization (TAE) has been widely performed for renal angiomyolipomas (AMLs) as prophylaxis or emergency treatment. On the other hand, mammalian target of rapamycin (mTOR) inhibitors have recently been used for tuberous sclerosis (TSC)-related AMLs, and no comparison between the effectiveness of mTOR inhibitors versus prophylactic selective TAE has yet been performed. Therefore, the purpose of this study was to evaluate the efficacy of TAE for AML tumor volume reduction and predictors of tumor volume decrease over 50%, with reference to the EXIST-2 trial. Methods A total of 44 patients who underwent 48 prophylactic embolization procedures for 50 AMLs in a single institution between 2004 and 2018 were included. Indications for TAE of AMLs were tumor size ≥4 cm or aneurysm ≥5 mm in diameter on contrast-enhanced computed tomography (CECT). Microspheres, ethanol, and micro-coils were used as embolic agents. The percentage volume reduction from before TAE to the minimum volume during follow-up after TAE was calculated, and predictors for 50% volume reduction were identified by univariate and multivariate binary logistic regression analyses. Results The technical success rate was 100% (50 of 50). No severe acute complications related to the procedure were encountered. Tumor volume reduction of ≥50% was observed in 35/50 AMLs. There was a significant difference in the rate of tumor volume reduction of 50% between the presence and absence of an aneurysm ≥5 mm and between tumor diameter ≥ 70 mm and < 70 mm on univariate analysis. On multivariate analysis, tumor diameter < 70 mm was the only independent predictor of significant tumor volume reduction after TAE. Conclusion Prophylactic selective TAE for AMLs has good tumor-reduction effects, especially for AMLs with tumor diameter < 70 mm.http://link.springer.com/article/10.1186/s42155-020-00179-2Kidney neoplasmsAngiomyolipomaEmbolizationTherapeuticTuberous sclerosis
spellingShingle Hidenari Hongyo
Hiroki Higashihara
Keigo Osuga
Eiji Kashiwagi
Shinya Kosai
Keisuke Nagai
Kaishu Tanaka
Yusuke Ono
Takeshi Ujike
Motohide Uemura
Ryoichi Imamura
Norio Nonomura
Noriyuki Tomiyama
Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
CVIR Endovascular
Kidney neoplasms
Angiomyolipoma
Embolization
Therapeutic
Tuberous sclerosis
title Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
title_full Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
title_fullStr Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
title_full_unstemmed Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
title_short Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction
title_sort efficacy of prophylactic selective arterial embolization for renal angiomyolipomas identifying predictors of 50 volume reduction
topic Kidney neoplasms
Angiomyolipoma
Embolization
Therapeutic
Tuberous sclerosis
url http://link.springer.com/article/10.1186/s42155-020-00179-2
work_keys_str_mv AT hidenarihongyo efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT hirokihigashihara efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT keigoosuga efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT eijikashiwagi efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT shinyakosai efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT keisukenagai efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT kaishutanaka efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT yusukeono efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT takeshiujike efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT motohideuemura efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT ryoichiimamura efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT noriononomura efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction
AT noriyukitomiyama efficacyofprophylacticselectivearterialembolizationforrenalangiomyolipomasidentifyingpredictorsof50volumereduction